COMMUNIQUÉS West-GlobeNewswire

BioDelivery Sciences Expands Upon Report from Pain Management Task Force
24/06/2019
Company’s Activities Support Buprenorphine Recommendations Including: Primary Use of Buprenorphine in Chronic Pain when Clinically Indicated Having Payers Provide Coverage and Reimbursement for Buprenorphine for Chronic [...]
Entasis Therapeutics Appoints David Meek as Chairman of the Board
24/06/2019
WALTHAM, Mass., June 24, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, [...]
Progenics Pharmaceuticals Files Supplemental Investor Presentation Rebutting Velan’s Latest Inaccurate Claims
24/06/2019
Board has Positioned Progenics to Maximize Value as a Result of Proactive and Deliberate Strategy Velan’s Baseless Criticisms about the Development of AZEDRA and 1095 Reveal a Fundamental Lack of Understanding of [...]
Blueberries Announces Appointment of Chief Financial Officer
24/06/2019
TORONTO, June 24, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. ( CSE: BBM ) (OTCQB: BBRRF) (FRA: 1OA) (" Blueberries " or the " Company "), a leading Latin American licensed producer of medicinal cannabis and [...]
Minerva Neurosciences Announces Achievement of Primary and Key Secondary Objectives in Phase 2b Clinical Trial of Seltorexant (MIN-202) in Insomnia
24/06/2019
Primary endpoint, defined as Latency to Persistent Sleep (LPS) at Night 1, showed improvement with a p-value ≤0.001 after treatment with 10 and 20 mg doses of seltorexant Key secondary endpoint, defined as Wake After [...]
Transactions under Novozymes’ stock buyback program
24/06/2019
Please read the full announcement in the attached PDF Attachment 2019_20_Stock_Buybackprogram_EN
Emerald Health Therapeutics reçoit un permis de culture pour une nouvelle exploitation de cannabis biologique en Colombie-Britannique
24/06/2019
Les installations biologiques se composent de 14 492 m² répartis sur deux serres et potentiellement de 9,7 ha de culture en plein air VANCOUVER, Colombie-Britannique, 24 juin 2019 (GLOBE NEWSWIRE) -- Emerald Health [...]
Share buy-back week 25/2019
24/06/2019
Announcement 24 June 2019 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 2/2019 Coloplast has initiated the second part of the share buy-back programme totalling up [...]
Axovant Announces Poster Presentations at the 5th Congress of the European Academy of Neurology
24/06/2019
-Details from ongoing SUNRISE-PD Phase 2 trial of AXO-Lenti-PD and AXO-AAV-GM2 program highlighted in poster presentations- BASEL, Switzerland, June 24, 2019 (GLOBE NEWSWIRE) -- Axovant Gene Therapies Ltd. (NASDAQ: AXGT [...]
Kymab and LifeArc enter strategic partnership to discover new medicines using Kymab’s IntelliSelect® technologies
24/06/2019
Kymab and LifeArc enter strategic partnership to discover new medicines using Kymab’s IntelliSelect® technologies LifeArc will make a US$30 million equity investment in Kymab LifeArc to gain access to IntelliSelect [...]
CureVac Welcomes Two Members to its Supervisory Board
24/06/2019
Timothy Wright, M.D. and Craig Tooman Bring Unique Backgrounds and Rich Experiences to the Company TÜBINGEN, Germany and BOSTON, June 24, 2019 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated biopharmaceutical company [...]
Trevena Announces Publication of APOLLO-2 Results in Pain Practice
24/06/2019
CHESTERBROOK, Pa., June 24, 2019 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN) , a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with Central Nervous [...]
Applied Therapeutics Announces Initiation of Phase 1/2 Study of AT-007 in Galactosemia
24/06/2019
NEW YORK, June 24, 2019 (GLOBE NEWSWIRE) -- Applied Therapeutics Inc. (Nasdaq:APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in [...]
BrainsWay Announces Shipment of 100th Deep Transcranial Magnetic Stimulation Helmet for the Treatment of Obsessive-Compulsive Disorder
24/06/2019
Since receiving De Novo clearance from FDA in August 2018, the Company has shipped OCD coils to 100 sites across the U.S. JERUSALEM and HACKENSACK, N.J., June 24, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & [...]
Emerald Health Therapeutics Receives Cultivation License for New-Build Organic Cannabis Operation in British Columbia
24/06/2019
Organic facility consists of 156,000 sq. ft. in two greenhouses and potentially up to 24 acres of outdoor growing VANCOUVER, British Columbia, June 24, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“ [...]
Innovate Biopharmaceuticals Expands Its Management team with the Addition of Ed Sitar as Its Chief Financial Officer
24/06/2019
Innovate intends to focus on non-dilutive sources of capital to further develop its pipeline, including out-licensing of (i) selective ex-US rights to INN-202 for celiac disease and (ii) Innovate’s earlier clinical [...]
Syneos Health Introduces FSP 360 – Next Evolution Model Provides Customers Broadest Range of Functional Service Provider Solutions
24/06/2019
Evolved Model Delivers Customized Solutions Across Entire Asset Portfolio MORRISVILLE, N.C., June 24, 2019 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions [...]
Pluristem Completes Transition Period of Co-CEO Structure Yaky Yanay appointed as Chief Executive Officer and Zami Aberman appointed as Executive Chairman of the Board
24/06/2019
HAIFA, Israel, June 24, 2019 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc . (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing novel placenta-based cell therapy products, today announced the [...]
Axsome Therapeutics Initiates GEMINI Phase 3 Trial of AXS-05 in Major Depressive Disorder
24/06/2019
First patient enrolled in placebo-controlled GEMINI study Topline results anticipated in 2H 2019 NEW YORK, June 24, 2019 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical [...]

Pages